Multi-interacting global-change drivers reduce photosynthetic and resource use efficiencies and prompt a microzooplankton-phytoplankton uncoupling in estuarine communities.

Plankton communities are subjected to multiple global change drivers; however, it is unknown how the interplay between them deviates from predictions based on single-driver studies, in particular when trophic interactions are explicitly considered. We investigated how simultaneous manipulation of temperature, pH, nutrient availability and solar radiation quality affects the carbon transfer from phytoplankton to herbivorous protists and their potential consequences for ecosystem functioning. Our results showed that multiple interacting global-change drivers reduced the photosynthetic (gross primary production-to-electron transport rates ratios, from 0.

Beyond-local neural information processing in neuronal networks.

While there is much knowledge about local neuronal circuitry, considerably less is known about how neuronal input is integrated and combined across neuronal networks to encode higher order brain functions. One challenge lies in the large number of complex neural interactions. Neural networks use oscillating activity for information exchange between distributed nodes.

Antibody selection and automated quantification of TRPV1 immunofluorescence on human skin.

Assessing localization of the transient receptor potential vanilloid-1 (TRPV1) in skin nerve fibers is crucial for understanding its role in peripheral neuropathy and pain. However, information on the specificity and sensitivity of TRPV1 antibodies used for immunofluorescence (IF) on human skin is currently lacking. To find a reliable TRPV1 antibody and IF protocol, we explored antibody candidates from different manufacturers, used rat DRG sections and human skin samples for screening and human TRPV1-expressing HEK293 cells for further validation.

Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia.

This study evaluated patient-reported outcomes (PROs) of Medicine Access Programmes (MAPs) for Australian metastatic breast cancer patients on ribociclib. Limited patient awareness of MAP enrolment was identified, emphasising the need for improved education and consent processes. Most patients expressed gratitude for accessing non-funded medications and perceived enhanced medication adherence as a key benefit.